A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC)

被引：0
|
作者：
Evans, T. R. Jeffry
Eatock, Martin McKinlay
Lewsley, Liz-Anne
Kelly, Caroline
McCartney, Elaine
Duffton, Aileen
Houston, Peter
Harrison, Claire
Purcell, Colin
Ashton, Miranda
Morton, Alanna
Graham, Jill
Chalmers, Anthony J.
Thomson, Fiona
Pou, Chantevy
Bilsland, Alan
Cooke, Susie
McIntosh, David
Grose, Derek B.
机构：
[1] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Belfast City Hosp, Belfast, Antrim, North Ireland
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland
[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[6] N Ireland Canc Ctr, Belfast, Antrim, North Ireland
[7] Northern Ireland Canc Ctr, Belfast, Antrim, North Ireland
[8] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
709
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Capecitabine-based Chemoradiotherapy (CRT) for Locally Advanced Pancreatic Cancer (LAPC): Efficacy and Toxicity
    Jackson, A.
    Jain, P.
    Watkins, G.
    Valle, J.
    Taylor, M.
    Dickinson, C.
    Price, P.
    Saleem, A.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 270 - 270
  • [2] Genotype-driven phase I study of weekly irinotecan in combination with capecitabine-based neoadjuvant chemoradiation for locally advanced rectal cancer
    Zhu, Ji
    Li, Xinxiang
    Shen, Yunzhu
    Guan, Yun
    Gu, Weilie
    Lian, Peng
    Sheng, Weiqi
    Cai, Sanjun
    Zhang, Zhen
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (01) : 143 - 148
  • [3] Long-term outcome from the SCALOP trial: a multi-centre randomized phase II trial of gemcitabine or capecitabine-based chemoradiation (CRT) for locally advanced pancreatic cancer (LAPC)
    Hurt, C.
    Bridgewater, J.
    Falk, S.
    Cummins, S.
    Wasan, H.
    Crosby, T.
    Radhakrishna, G.
    Jephcott, C.
    Roy, R.
    McDonald, A.
    Ray, R.
    Joseph, G.
    Staffurth, J.
    Abrams, R.
    Griffiths, G.
    Maughan, T.
    Mukherjee, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 118 - 119
  • [4] Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer (LAPC)
    Skinner, Heath Devin
    Javle, Milind M.
    Wolff, Robert A.
    Clemons, Marilyn V.
    Munsell, Mark F.
    Delclos, Marc E.
    Fleming, Jason B.
    Das, Prajnan
    Crane, Christopher H.
    Krishnan, Sunil
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [5] Phase II Trial of Neoadjuvant Capecitabine (Cp) with Irinotecan (Ir) followed by Capecitabine-based Chemoradiotherapy (CRT) for Patients (pts) with Locally Advanced Rectal Cancer (LARC): A Hoosier Oncology Group Study
    Cardenes, H.
    Sanghani, S.
    Burns, M.
    Robb, B.
    Hinkle, D.
    Johnson, C.
    Yu, M.
    Currie, C.
    Loehrer, P.
    Chiorean, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S54 - S54
  • [6] Efficacy and toxicity of limited field concurrent chemoradiotherapy (CRT) with capecitabine for locally advanced pancreatic cancer (LAPC)
    Jain, P.
    Watkins, G.
    Jackson, A.
    Dickinson, C.
    Whitfield, G.
    Rembielak, A.
    Valle, J. W.
    Taylor, M. B.
    Price, P. M.
    Saleem, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II trial of neoadjuvant capecitabine (C) with irinotecan (I) followed by capecitabine-based chemoradiotherapy (CRT) for patients (pts) with locally advanced rectal cancer (LARC): HOG GI03-53
    Cardenes, H. R.
    Sanghani, S.
    Burns, M.
    Robb, M.
    Hinkle, D. T.
    Johnson, C. S.
    Yu, M.
    Currie, C. R.
    Loehrer, P. J.
    Chiorean, E. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Phase I study of preoperative chemoradiation with temozolomide and capecitabine in patients with locally advanced rectal cancer
    Hong, Yong Sang
    Park, Seong Joon
    Kim, Jeong Eun
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Park, Jin-hong
    Kim, Jong Hoon
    Yu, Chang Sik
    Kim, Jin Cheon
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Phase II study of preoperative chemoradiation (CRT) with cetuximab, irinotecan and capecitabine in patients with locally advanced resectable rectal cancer
    Hong, Y. S.
    Kim, D. Y.
    Lee, K. S.
    Lim, S. B.
    Choi, H. S.
    Jeong, S. Y.
    Kim, J. H.
    Im, S. A.
    Kim, T. W.
    Jung, K. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Induction FOLFIRINOX followed by chemoradiation with capecitabine for unresectable locally advanced pancreatic cancer (LAPC): Preliminary data.
    de Carvalho, Rafael Ferreira
    Gil, Erlon
    Moreira, Raphael Brandao
    Peixoto, Renata D'Alpino
    Fernandes Amarante, Marcus Paulo
    Zanuncio, Pedro
    Ferrigno, Robson
    Moraes, Paulo
    Maluf, Fernando C.
    Buzaid, Antonio C.
    De Sousa Cruz, Marcelo Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345